Caffeic Acid Phenethyl Ester

Catalog No.S7414 Synonyms: CAPE, Phenylethyl Caffeate

Molecular Weight(MW): 284.31

Caffeic acid phenethyl ester is a potent and specific inhibitor of NF-κB activation, and also displays antioxidant, immunomodulatory and antiinflammatory activities.

Cited by 13 Publications

J Biol Chem, 2019, 294(18):7221-7230

PubMed: 30846565 ( click the link to review the publication )

Cancer Res, 2018, 78(19):5586-5599

PubMed: 30012671 ( click the link to review the publication )

Carbohydr Polym, 2018, 202:134-142

PubMed: 30286986 ( click the link to review the publication )

Int J Mol Med, 2018, 41(1):555-563

PubMed: 29115406 ( click the link to review the publication )

Am J Physiol Cell Physiol, 2017, 313(6):C612-C620

PubMed: 29021196 ( click the link to review the publication )

Mol Med Rep, 2017, 16(4):4922-4926

PubMed: 28849197 ( click the link to review the publication )

Life Sci, 2017, 191:132-140

PubMed: 29080695 ( click the link to review the publication )

Int Immunopharmacol, 2017, 53:17-23

PubMed: 29031143 ( click the link to review the publication )

Mol Carcinog, 2017, 56(11):2434-2445

PubMed: 28618089 ( click the link to review the publication )

Tumour Biol, 2016, 37(9):12731-12742

PubMed: 27448305 ( click the link to review the publication )

Oncotarget, 2016, 7(25):38539-38550

PubMed: 27413117 ( click the link to review the publication )

Sci Rep, 2015, 5:12580

PubMed: 26219418 ( click the link to review the publication )

Oncotarget, 2014, 5(23):12189-202

PubMed: 25361008 ( click the link to review the publication )

5 Customer Reviews

The protein expression alteration of p-NF-κB, NF-κB, PD-L1 in NP-69-LMP1 or NP-69 cell lines treated with 0, 0.5, and 1.0 μM Caffeic Acid Phenethyl Ester (CAPE) for 72 hours. β-actin was used to verify equal loading.

Oncotarget, 2014, 5(23): 12189-202 . Caffeic Acid Phenethyl Ester purchased from Selleck.
Representative apoptosis assay of LPS141 cells. Summary of apoptosis assay results. Data represent % apoptotic cells ± standard deviation (SD, error bars).

Sci Rep, 2015, 5: 12580. Caffeic Acid Phenethyl Ester purchased from Selleck.
HH1-1 promoted immune responses by activation of NF-κB signaling.

Carbohydr Polym, 2018, 202:134-142. Caffeic Acid Phenethyl Ester purchased from Selleck.
PC cells were treated with 5 μM CAPE for 24 h, and EMT markers were detected (n=3/group). * P < 0.05, ** P < 0.01, and *** P < 0.001

Oncotarget, 2016, 7(25):38539-38550. Caffeic Acid Phenethyl Ester purchased from Selleck.
Cells were treated with the NFκB inhibitor CAPE, which significantly decreased the CRH-induced IL-6 expression.

Mol Carcinog, 2017, 56(11):2434-2445. Caffeic Acid Phenethyl Ester purchased from Selleck.

Purity & Quality Control

Choose Selective NF-κB Inhibitors

Biological Activity

Description

Caffeic acid phenethyl ester is a potent and specific inhibitor of NF-κB activation, and also displays antioxidant, immunomodulatory and antiinflammatory activities.

Targets

NF-κB ^[1]

In vitro

Caffeic acid phenethyl ester blocks NF-κB activation induced by phorbol ester, ceramide, okadaic acid, and hydrogen peroxide by preventing the translocation of the p65 subunit of NF-κB to the nucleus. ^[1] In a series of tumor cell lines, Caffeic acid phenethyl ester shows promising antiproliferative activity with EC50 of 1.76, 3.16, 13.7, and 44.0 μM against murine colon 26-L5, murine B16-BL6 melanoma, human HT-1080 fibrosarcoma and human lung A549 adenocarcinoma cell lines, respectively. ^[2] Caffeic acid phenethyl ester, as a potent antioxidant, exerts its anti-apoptotic effect in cerebellar granule cells by blocking ROS formation and inhibiting caspase activity. ^[3] Moreover, Caffeic acid phenethyl ester attenuates the pro-inflammatory phenotype of LPS-stimulated HSCs, and LPS-induced sensitization of HSCs to fibrogenic cytokines by inhibiting NF-κB signaling. ^[4]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Activity Description	PMID
mouse RAW264.7 cells	MULGeY5kfGmxbjDhd5NigQ>?		NX3rbIJZOjRiaB?=	M2jr[WlvcGmkaYTpc44hd2ZiTGDTMYlv\HWlZXSgcol1emmlIH;4bYRmKHC{b3T1Z5Rqd25iaX6gcY92e2ViUlHXNlY1NjdiY3XscJMh[XO\|ZYPz[YQh[XNibnn0dol1\SCjY3P1cZVt[XSrb36gZYRucW6rc4TldoVlKDFiaIKgZoVnd3KnIFzQV{BkcGGubHXu[4Uh[W6mIH3lZZN2emWmIHHmeIVzKDJ2IHjyd{BjgSCJcnnld5MhemWjZ3XueEBie3OjeTygSWM2OD1yLkG5N{DPxE1?	NWHEXFVYOTh4NkezNlA>
mouse 26-L5 cells	MnrvVJJwdGmoZYLheIlwdiCjc4PhfS=>		MlfHO\|IhcA>?	M4\HSGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgcY92e2ViMk[tUFUh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygSWM2OD1yLkOg{txO	M4HJSVEzODJ5N{O5
human HeLa cells	MULQdo9tcW[ncnH0bY9vKGG\|c3H5		MmKzO\|IhcA>?	NFexN3dCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjlUIEh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygSWM2OD1{LkO2JO69VQ>?	MV:xNlAzPzd\|OR?=
human Bewo cells	NIW2NW9HfW6ldHnvckBie3OjeR?=			MVjBcpRqfHWvb4KgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCEZYfvJINmdGy\|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiY3XscEBoem:5dHigZpkhVVSWIHHzd4F6NCCLQ{WwQVIvQTZizszN	NITBcZYzPTF4MEizOy=>
mouse J774.1 cells	MWTGeY5kfGmxbjDhd5NigQ>?		M1\uW\|I1KGh?	MVrJcohq[mm2aX;uJI9nKEySUz3pcoR2[2WmIF7PJJBzd2S3Y4Tpc44hcW5ibX;1d4UhUjd5ND6xJINmdGy\|IHHmeIVzKDJ2IHjyd{BjgSCJcnnld5MhemWjZ3XueEBie3OjeTygTWM2OD12Lkig{txO	Mn7aNVU6PzR4MEi=
human Bel7402 cells	MYTDfZRwfG:6aXRCpIF{e2G7			M1X5bGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGJmdDd2MEKgZ4VtdHNiYomgUXRVKGG\|c3H5MEBKSzVyPUWuOUDPxE1?	MVKxPFk2OjR{MB?=
human LNCAP cells	M2fkdWZ2dmO2aX;uJIF{e2G7		MXiyOEBp	NEjzblFCdnSrYX7kdo9o\W6rYzDhZ5Rqfmm2eTDpckBpfW2jbjDMUmNCWCClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gSGhVNXO2aX31cIF1\WRiUGPBJJJmdGWjc3WgZYZ1\XJiMkSgbJJ{KGK7IFXMTXNCNCCLQ{WwQVYvOiCwTR?=	M{jHRVI1ODhyMUC1
mouse BV2 cells	NVjCPIpbTnWwY4Tpc44h[XO\|YYm=		M1\oW\|I1KGh?	M{LqfWlvcGmkaYTpc44hd2Zibnn0dolkKG:6aXTlJJBzd2S3Y4Tpc44hcW5iTGDTMZN1cW23bHH0[YQhdW:3c3WgRnYzKGOnbHzzJJRz\WG2ZXSgN{BpenNiYnXmc5JmKEySUzDh[IRqfGmxbjDt[YF{fXKnZDDh[pRmeiB{NDDodpMh[nliR4Lp[ZN{KGG\|c3H5MEBKSzVyPU[uOEDPxE1?	NF;nZVUzOzh5MEewNC=>
mouse B16-BL6 cells	MofBVJJwdGmoZYLheIlwdiCjc4PhfS=>		NIPje4k4OiCq	MmGwRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDtc5V{\SCEMU[tRmw3KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO\|YYmsJGVEPTB;Nj63PUDPxE1?	NF\LfW4yOjB{N{ezPS=>
HUVEC cells	MXHDfZRwfG:6aXRCpIF{e2G7		NEP5PXkyQCCq	NYTBe41sS3m2b4Dyc5Rm[3SrdnWgZYN1cX[rdImgZYdicW6\|dDDINm8zNWmwZIXj[YQhd3irZHH0bZZmKHO2cnXzd{BqdiCKVW\FR{Bk\WyuczDh[pRmeiBzODDodpMh[nliQ3XscE1VcXSncjDCcJVmKGG\|c3H5	MnLtNlA2QTh6OUS=
human HT1080 cells	NUTr[\|hGWHKxbHnm[ZJifGmxbjDhd5NigQ>?		M{fQZVczKGh?	NGLwdppCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjUNVA5OCClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG\|c3H5MEBGSzVyPUmuOUDPxE1?	NUDyTpJqOTJyMke3N\|k>
human HL60 cells	M4G3OWN6fG:2b4jpZ:Kh[XO\|YYm=		NYjPRWtEPzJiaB?=	M2TJe2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhNPjBiY3XscJMh[W[2ZYKgO\|IhcHK\|IHL5JG1VXCCjc4PhfUwhUUN3ME25Mlgh\|ryP	M1TOUVIxPjd\|N{K3
human LS 174T cells	MlvZR5l1d3SxeHnjxsBie3OjeR?=		NEexUnk4OiCq	Ml\mR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUHMhOTd2VDDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{[wQVkvQSEQvF2=	MXSyNFY4Ozd{Nx?=
human SGC7901 cells	MXrGeY5kfGmxbjDhd5NigQ>?			NXPKdXBESW62aYT1cY9zKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV2dEPzlyMTDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKGOnbHyg[5Jwf3SqIHL5JG1VXCCjc4PhfUwhUUN3ME2xOE4zPiEQvF2=	NU\UdXdOOjVzNkC4N\|c>
human Bel7404 cells	MXTDfZRwfG:6aXRCpIF{e2G7		NVXWb5ZOPzJiaB?=	NH:zRmlEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBD\Wx5NEC0JINmdGy\|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:OTRwNTFOwG0>	NUPyTWtxOjB4N{O3Nlc>
human BGC823 cells	M2nlRWN6fG:2b4jpZ:Kh[XO\|YYm=		MmPUO\|IhcA>?	MYrDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDCS2M5OjNiY3XscJMh[W[2ZYKgO\|IhcHK\|IHL5JG1VXCCjc4PhfUwhUUN3ME2xPU4{KM7:TR?=	NFHKWo0zODZ5M{eyOy=>
human HO8910 cells	M4LvWmN6fG:2b4jpZ:Kh[XO\|YYm=		Mnm2O\|IhcA>?	NIfBOZREgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJVzh7MUCgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF0zPS53IN88US=>	M3G1W\|IxPjd\|N{K3
human MCF7 cells	NUfUb5U3S3m2b4TvfIlkyqCjc4PhfS=>			M3;wOWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1ETjdiY3XscJMh[nliTWTUJIF{e2G7LDDJR\|UxRTJ4Lkeg{txO	NEDBbVkyQDl3MkSyNC=>
human A549 cells	MX7DfZRwfG:6aXRCpIF{e2G7		NYTmOXBlPzJiaB?=	MW\DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO\|YYmsJGlEPTB;Mk[uPEDPxE1?	Mn6wNlA3PzN5Mke=
human LNCAP cells	MkHUR5l1d3SxeHnjxsBie3OjeR?=		MmnQNlQhcA>?	MVHDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDMUmNCWCClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4VtdCC4aXHibYxqfHliYX\0[ZIhOjRiaILzJIJ6KFeVVD2xJIF{e2G7LDDJR\|UxRTN\|Lkeg{txO	MnzvNlQxQDBzMEW=
human HeLa cells	NH7yVJJHfW6ldHnvckBie3OjeR?=			NYjTVmszSW62aYT1cY9zKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTIVN[SClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJINmdGxiZ4Lve5RpKGK7IF3UWEBie3OjeTygTWM2OD1\|Nz65PEDPxE1?	NX\JPWtoOjVzNkC4N\|c>
human HepG2 cells	NWjReIpJTnWwY4Tpc44h[XO\|YYm=			Mnv6RY51cXS3bX;yJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSHXwS\|Ih[2WubIOgZZN{\XO\|ZXSgZZMhcW6qaXLpeIlwdiCxZjDj[YxtKGe{b4f0bEBjgSCPVGSgZZN{[XluIFnDOVA:PDBwOEeg{txO	MW[yOVE3ODh\|Nx?=
human ECA109 cells	M1TLRmN6fG:2b4jpZ:Kh[XO\|YYm=		NILZS\|E4OiCq	NEfQVlREgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBGS0FzMEmgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF01Oi54IN88US=>	NGn5[IgzODZ5M{eyOy=>
human BCG823 cells	NGTZfYhEgXSxdH;4bYPDqGG\|c3H5			MUXDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDCR2c5OjNiY3XscJMh[nliTWTUJIF{e2G7LDDJR\|UxRTR2Lk[g{txO	MkDrNVg6PTJ2MkC=
human KB cells	NYDQSYhLS3m2b4TvfIlkyqCjc4PhfS=>		MXO3NkBp	MlrpR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gT2Ih[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OD12NT6yJO69VQ>?	MUGyNFY4Ozd{Nx?=
human K562 cells	M3jISmN6fG:2b4jpZ:Kh[XO\|YYm=		M{HGO\|czKGh?	M4DrTWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGs2PjJiY3XscJMh[W[2ZYKgO\|IhcHK\|IHL5JG1VXCCjc4PhfUwhUUN3ME20OkDPxE1?	MmXsNlA3PzN5Mke=
rat VSMC	MkfxSpVv[3Srb36gZZN{[Xl?	MmrqOUDPxE1?	MUezNEBucW6\|	NIHieYlF\WO{ZXHz[UBqdiCrboTyZYNmdGy3bHHyJHJQWyCuZY\lcEBqdiCSRFfGMZN1cW23bHH0[YQhemG2IG\TUWMh[XRiNTD1UUBxemW2cnXheIVlKHerdHigZ49ueG:3bnSg[o9zKDNyIH3pcpMhdWWjc4Xy[YQh[W[2ZYKgeZAhfG9iMkOgbJJ{KG:oIIDvd5Qhe3SrbYXsZZRqd25idYPpcochUDKGQ1[gZpkh\myxdzDjfZRwdWW2cnnjJIFv[Wy7c3nz	NXvsSXc1OjF{NkW1OVQ>
rat PC12 cells	MW\GeY5kfGmxbjDhd5NigQ>?	M2\mSVIvPSEQvF2=	MoPoN{Bp	MXfO[ZVzd3C{b4TlZ5RqfmViYXP0bZZqfHliYXfhbY5{fCCKMl:yMYlv\HWlZXSg[IFu[WenIHnuJJJifCCSQ{GyJINmdGy\|IHHzd4V{e2WmIHHzJINmdGxidnnhZoltcXS7IHH0JFIvPSC3TTDwdoVqdmO3YnH0[YQh\m:{IEOgbJJ{KG[xbHzve4VlKGK7IFiyU\|Ih[2ijbHzlcodmKG2nYYP1doVlKGGodHXyJFUhcHK\|IHL5JG1VXCCjc4PhfS=>	MVqyOFY6PzN\|NR?=

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	p-p65 / CDH6 / RUNX2 / E-cadherin / N-cadherin / Vimentin / Slug / Snail ; PubMed: 29284791 Oncogenesis c/ Effect of Caffeic acid phenethyl ester on the expression of EMT markers, CDH6 and RUNX2 detected by western blotting analysis. e/ Effect of Caffeic acid phenethyl ester on the expression of EMT markers, CDH6 and RUNX2. Nrf2; PubMed: 28275300 World J Gastroenterol A: HSC-T6 cells were treated with 5 μmol/L, 10 μmol/L and 15 μmol/L CAPE for 24 h. Nrf2 mRNA and cytosol and nuclear protein expression levels were investigated using real-time PCR and Western blot, respectively AKT / AKT1 / AKT2 / AKT3 / p-AKT / FOXO1 / FOXO3a / p-FOXO1 / p-FOXO3a / Skp2 / p27(Kip) / Cyclin D1 / Rb / p-Rb ; PubMed: 23615471 Int J Mol Sci Effects of CAPE treatment on the abundance and phosphorylation status of signaling proteins. Protein expression of total Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr308, GSK3β, Rb, phospho-Rb Ser807/811, cyclin D1, and Skp2, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FOXO3a Thr32, NF-κB, phospho-NF-κB Ser536, p27(Kip), and β-actin in TW2.6 cells treated with 0, 50, or 100 μM CAPE for 48 h were assayed by Western blotting. Experiments were repeated three times.	29284791 28275300 23615471
Immunofluorescence	NF-κB; PubMed: 29284791 Oncogenesis NF-κB localization detected by IF assay in C666-1 cells when treated with Caffeic acid phenethyl ester. DMSO was the negative control. Green, p65; blue, H33342 staining (nuclei). In-NF-κB represents NF-κB inhibitor (the Caffeic acid phenethyl ester)	29284791
Growth inhibition assay	Cell number; PubMed: 23615471 Int J Mol Sci Effect of caffeic acid phenethyl ester (CAPE) on viability and proliferation of TW2.6 oral cancer cells. TW2.6 oral cancer cells were treated with increasing concentrations of CAPE for 24, 48, or 96 h and determined by Hoechst dye 33258-based 96-well proliferation assay (A) or by MTT (3,4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide) 96-well assay (B), respectively, as described in Material and Methods. Cell numbers were normalized to control (DMSO treatment) of each treatment period. The mean and standard deviation represented the average and standard deviation respectively of the results from all 36 wells in the three experiments. Asterisk *** represents statistically significant difference p < 0.001 between the treated group and the control group.	23615471

In vivo

In vivo, Caffeic acid phenethyl ester (10 mg/kg, i.p.) inhibits the growth and angiogenesis of primary tumors in C57BL/6 and BALB/c mice inoculated with Lewis lung carcinoma, colon carcinoma, and melanoma cells. ^[5] Caffeic acid phenethyl ester (5, 10, 20 mg/kg) also shows immunomodulatory effects in vivo by decreasing thymus weight and/or cellularity of thymus and spleen. ^[6]

Protocol

Cell Research: ^[2]	- Collapse Cell lines: Murine colon 26-L5, murine B16-BL6 melanoma, human HT-1080 fibrosarcoma and human lung A549 adenocarcinoma cell lines Concentrations: ~200 μM Incubation Time: 3 days Method: Human HT-1080 fibrosarcoma, human lung A549 adenocarcinoma and murine B16-BL6 melanoma cell lines are maintained in EMEM medium supplemented with 10% FCS, 0.1% sodium bicarbonate and 2 mM glutamine. Murine colon 26-L5 carcinoma cell line, on the other hand, is maintained in RPMI medium containing the same supplements as in EMEM. These are all highly metastatic cell lines except for A-549 carcinoma. Cellular viability is determined using the standard MTT assay. In brief, exponentially growing cells are harvested and 100 μl of cell suspension containing 2000 cells is plated in 96-well microtiter plates. After 24 h of incubation to allow for cell attachment, the cells are treated with varying concentrations of test samples in medium (100 μl) and incubated for 72 h at 37°C under 5% CO₂. Three hours after the addition of MTT, the amount of formazan formed is measured spectrophotometrically at 550 nm with a Perkin Elmer HTS-7000 plate reader. The test samples are first dissolved in DMSO and then diluted with medium; the final concentration of DMSO is less than 0.25%. Normal also had the same extent of DMSO. 5-Fluorouracil (5-FU) and doxorubicin HCl are used as positive controls, and EC50 values are calculated from the mean values of data from 4 wells. (Only for Reference)
Animal Research: ^[5]	- Collapse Animal Models: C57BL/6 and BALB/c mice inoculated with Lewis lung carcinoma, colon carcinoma, and melanoma cells Formulation: PBS Dosages: ~10 mg/kg Administration: i.p. (Only for Reference)

Cell Research:

^[2]

- Collapse

Cell lines: Murine colon 26-L5, murine B16-BL6 melanoma, human HT-1080 fibrosarcoma and human lung A549 adenocarcinoma cell lines
Concentrations: ~200 μM
Incubation Time: 3 days
Method:
Human HT-1080 fibrosarcoma, human lung A549 adenocarcinoma and murine B16-BL6 melanoma cell lines are maintained in EMEM medium supplemented with 10% FCS, 0.1% sodium bicarbonate and 2 mM glutamine. Murine colon 26-L5 carcinoma cell line, on the other hand, is maintained in RPMI medium containing the same supplements as in EMEM. These are all highly metastatic cell lines except for A-549 carcinoma. Cellular viability is determined using the standard MTT assay. In brief, exponentially growing cells are harvested and 100 μl of cell suspension containing 2000 cells is plated in 96-well microtiter plates. After 24 h of incubation to allow for cell attachment, the cells are treated with varying concentrations of test samples in medium (100 μl) and incubated for 72 h at 37°C under 5% CO₂. Three hours after the addition of MTT, the amount of formazan formed is measured spectrophotometrically at 550 nm with a Perkin Elmer HTS-7000 plate reader. The test samples are first dissolved in DMSO and then diluted with medium; the final concentration of DMSO is less than 0.25%. Normal also had the same extent of DMSO. 5-Fluorouracil (5-FU) and doxorubicin HCl are used as positive controls, and EC50 values are calculated from the mean values of data from 4 wells.

(Only for Reference)

Animal Research:

^[5]

- Collapse

Animal Models: C57BL/6 and BALB/c mice inoculated with Lewis lung carcinoma, colon carcinoma, and melanoma cells
Formulation: PBS
Dosages: ~10 mg/kg
Administration: i.p.
(Only for Reference)

References

- Collapse

Solubility (25°C)

In vitro	DMSO	57 mg/mL (200.48 mM)
	Ethanol	57 mg/mL (200.48 mM)
	Water	Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information Download Caffeic Acid Phenethyl Ester SDF

Molecular Weight	284.31
Formula	C₁₇H₁₆O₄
CAS No.	104594-70-9
Storage	3 years -20°C powder
Storage	2 years -80°C in solvent
Synonyms	CAPE, Phenylethyl Caffeate

Bio Calculators

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration _(start) x Volume _(start) = Concentration _(final) x Volume _(final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

Serial Dilutions
Concertration (start):
Dilution-folds:

Computed Result

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2019-10-14)

NCT Number	Recruitment	interventions	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT04031872	Not yet recruiting	Drug: LY3200882	Colorectal Cancer Metastatic	The Netherlands Cancer Institute\|Vall d''Hebron Institute of Oncology\|Agendia\|European Organisation for Research and Treatment of Cancer - EORTC\|Azienda Ospedaliera Niguarda Cà Granda\|Fundación para la Investigación del Hospital Clínico de Valencia\|University of Campania Luigi Vanvitelli\|University of Turin Italy\|Eli Lilly and Company\|Catalan Institute of Health\|Universitaire Ziekenhuizen Leuven	February 2020	Phase 1\|Phase 2
NCT03749863	Not yet recruiting	Procedure: Serial PRP injections	Presbylarynx\|Atrophy; Larynx\|Dysphonia\|Vocal Cord Atrophy\|Presbylarynges	University of Southern California	November 1 2019	Not Applicable
NCT03790956	Not yet recruiting	Procedure: Silk Microparticle Filler Injection	Vocal Cord Paralysis Unilateral\|Dysphonia\|Dysphagia Oropharyngeal	University of Southern California\|Sofregen Medical Inc.	October 1 2019	Not Applicable
NCT04088955	Recruiting	Other: DigiMeds	Colon Cancer\|Breast Cancer\|Rectal Cancer	Proteus Digital Health Inc.	September 2019	--
NCT04028674	Not yet recruiting	Device: Laryngeal Pacing Device\|Drug: Botulinum toxin type A	Bilateral Vocal Fold Paralysis (BVFP)	Vanderbilt University Medical Center\|National Institute on Deafness and Other Communication Disorders (NIDCD)	September 2019	Early Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

NF-κB Signaling Pathway Map

Related NF-κB Products

LY2409881 ^New

LY2409881 is a potent and selective IKK2 inhibitor with IC50 of 30 nM, >10-fold selectivity over IKK1 and other common kinases.
WS3 ^New

WS3 is a β cell proliferation inducer via modulation of Erb3 binding protein-1 (EBP1) and the IκB kinase pathway.
Andrographolide

Andrographolide is a labdane diterpenoid that is the main bioactive component of the medicinal plant Andrographis paniculata.
Sodium salicylate

Sodium salicylate is used in medicine as an analgesic and antipyretic.
QNZ (EVP4593)

QNZ (EVP4593) shows potent inhibitory activity toward both NF-κB activation and TNF-α production with IC50 of 11 nM and 7 nM in Jurkat T cells, respectively.
Sodium 4-Aminosalicylate

Sodium 4-Aminosalicylate is an antibiotic used to treat tuberculosis via NF-κB inhibition and free radical scavenging.

Features:5-Aminosalicylate is considered to be the active moiety of sulfasalazine.
SC75741

SC75741 is a potent NF-κB inhibitor with EC50 of 200 nM.
JSH-23

JSH-23 is an inhibitor of NF-κB transcriptional activity with IC50 of 7.1 μM in RAW 264.7 cell line.
BAY 11-7082

BAY 11-7082 is a NF-κB inhibitor, inhibits TNFα-induced IκBα phosphorylation with IC50 of 10 μM in tumor cells. Also inhibiting components of the ubiquitin system.

Choose Your Country or Region

By Signaling Pathways

By product type

Caffeic Acid Phenethyl Ester

Cited by 13 Publications

5 Customer Reviews

Purity & Quality Control

Choose Selective NF-κB Inhibitors

Biological Activity

Protocol

References

Solubility (25°C)

Chemical Information Download Caffeic Acid Phenethyl Ester SDF

Bio Calculators

Molarity Calculator

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

Dilution Calculator

Concentration _(start) x Volume _(start) = Concentration _(final) x Volume _(final)

The Serial Dilution Calculator Equation

Serial Dilutions

Computed Result

Molecular Weight Calculator

Total Molecular Weight: g/mol

Instructions to calculate molar mass (molecular weight) of a chemical compound:

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molarity Calculator

Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2019-10-14)

Tech Support

NF-κB Signaling Pathway Map

Related NF-κB Products

Choose Your Country or Region

By Signaling Pathways

By product type

Caffeic Acid Phenethyl Ester

Cited by 13 Publications

5 Customer Reviews

Purity & Quality Control

Choose Selective NF-κB Inhibitors

Biological Activity

Protocol

References

Solubility (25°C)

Chemical Information Download Caffeic Acid Phenethyl Ester SDF

Bio Calculators

Molarity Calculator

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

Dilution Calculator

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

The Serial Dilution Calculator Equation

Serial Dilutions

Computed Result

Molecular Weight Calculator

Total Molecular Weight: g/mol

Instructions to calculate molar mass (molecular weight) of a chemical compound:

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molarity Calculator

Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2019-10-14)

Tech Support

NF-κB Signaling Pathway Map

Related NF-κB Products

Concentration _(start) x Volume _(start) = Concentration _(final) x Volume _(final)